Variation in the availability and cost of essential medicines for non-communicable diseases in Uganda : A descriptive time series analysis
BACKGROUND: Availability of essential medicines for non-communicable diseases (NCDs) is poor in low- and middle-income countries. Availability and cost are conventionally assessed using cross-sectional data. However, these characteristics may vary over time.
METHODS: We carried out a prospective, descriptive analysis of the availability and cost of essential medicines in 23 Ugandan health facilities over a five-week period. We surveyed facility pharmacies in-person up to five times, recording availability and cost of 19 essential medicines for NCDs and four essential medicines for communicable diseases.
RESULTS: Availability of medicines varied substantially over time, especially among public facilities. Among private-for-profit facilities, the cost of the same medicine varied from week to week. Private-not-for-profit facilities experienced less dramatic fluctuations in price.
CONCLUSIONS: We conclude that there is a need for standardized, continuous monitoring to better characterize the availability and cost of essential medicines, understand demand for these medicines, and reduce uncertainty for patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
PloS one - 15(2020), 12 vom: 23., Seite e0241555 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Armstrong-Hough, Mari [VerfasserIn] |
---|
Links: |
---|
Themen: |
Drugs, Essential |
---|
Anmerkungen: |
Date Completed 11.01.2021 Date Revised 11.01.2021 published: Electronic-eCollection Citation Status MEDLINE |
---|
doi: |
10.1371/journal.pone.0241555 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM319265528 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM319265528 | ||
003 | DE-627 | ||
005 | 20231225171104.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1371/journal.pone.0241555 |2 doi | |
028 | 5 | 2 | |a pubmed24n1064.xml |
035 | |a (DE-627)NLM319265528 | ||
035 | |a (NLM)33362249 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Armstrong-Hough, Mari |e verfasserin |4 aut | |
245 | 1 | 0 | |a Variation in the availability and cost of essential medicines for non-communicable diseases in Uganda |b A descriptive time series analysis |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 11.01.2021 | ||
500 | |a Date Revised 11.01.2021 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Availability of essential medicines for non-communicable diseases (NCDs) is poor in low- and middle-income countries. Availability and cost are conventionally assessed using cross-sectional data. However, these characteristics may vary over time | ||
520 | |a METHODS: We carried out a prospective, descriptive analysis of the availability and cost of essential medicines in 23 Ugandan health facilities over a five-week period. We surveyed facility pharmacies in-person up to five times, recording availability and cost of 19 essential medicines for NCDs and four essential medicines for communicable diseases | ||
520 | |a RESULTS: Availability of medicines varied substantially over time, especially among public facilities. Among private-for-profit facilities, the cost of the same medicine varied from week to week. Private-not-for-profit facilities experienced less dramatic fluctuations in price | ||
520 | |a CONCLUSIONS: We conclude that there is a need for standardized, continuous monitoring to better characterize the availability and cost of essential medicines, understand demand for these medicines, and reduce uncertainty for patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Drugs, Essential |2 NLM | |
700 | 1 | |a Sharma, Srish |e verfasserin |4 aut | |
700 | 1 | |a Kishore, Sandeep P |e verfasserin |4 aut | |
700 | 1 | |a Akiteng, Ann R |e verfasserin |4 aut | |
700 | 1 | |a Schwartz, Jeremy I |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t PloS one |d 2006 |g 15(2020), 12 vom: 23., Seite e0241555 |w (DE-627)NLM167327399 |x 1932-6203 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2020 |g number:12 |g day:23 |g pages:e0241555 |
856 | 4 | 0 | |u http://dx.doi.org/10.1371/journal.pone.0241555 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2020 |e 12 |b 23 |h e0241555 |